| Bioactivity | Emfilermin is a recombinant human leukaemia inhibitory factor (LIF) that can be used in chemotherapy-induced peripheral neuropathy studies[1]. |
| Name | Emfilermin |
| CAS | 159075-60-2 |
| Sequence | Ser-Pro-Leu-Pro-Ile-Thr-Pro-Val-Asn-Ala-Thr-Cys-Ala-Ile-Arg-His-Pro-Cys-His-Asn-Asn-Leu-Met-Asn-Gln-Ile-Arg-Ser-Gln-Leu-Ala-Gln-Leu-Asn-Gly-Ser-Ala-Asn-Ala-Leu-Phe-Ile-Leu-Tyr-Tyr-Thr-Ala-Gln-Gly-Glu-Pro-Phe-Pro-Asn-Asn-Leu-Asp-Lys-Leu-Cys-Gly-Pro-Asn-Val-Thr-Asp-Phe-Pro-Pro-Phe-His-Ala-Asn-Gly-Thr-Glu-Lys-Ala-Lys-Leu-Val-Glu-Leu-Tyr-Arg-Ile-Val-Val-Tyr-Leu-Gly-Thr-Ser-Leu-Gly-Asn-Ile-Thr-Arg-Asp-Gln-Lys-Ile-Leu-Asn-Pro-Ser-Ala-Leu-Ser-Leu-His-Ser-Lys-Leu-Asn-Ala-Thr-Ala-Asp-Ile-Leu-Arg-Gly-Leu-Leu-Ser-Asn-Val-Leu-Cys-Arg-Leu-Cys-Ser-Lys-Tyr-His-Val-Gly-His-Val-Asp-Val-Thr-Tyr-Gly-Pro-Asp-Thr-Ser-Gly-Lys-Asp-Val-Phe-Gln-Lys-Lys-Lys-Leu-Gly-Cys-Gln-Leu-Leu-Gly-Lys-Tyr-Lys-Gln-Ile-Ile-Ala-Val-Leu-Ala-Gln-Ala-Phe(Disulfide bridge:Cys12-Cys134,Cys18-Cys131,Cys60-Cys163) |
| Shortening | SPLPITPVNATCAIRHPCHNNLMNQIRSQLAQLNGSANALFILYYTAQGEPFPNNLDKLCGPNVTDFPPFHANGTEKAKLVELYRIVVYLGTSLGNITRDQKILNPSALSLHSKLNATADILRGLLSNVLCRLCSKYHVGHVDVTYGPDTSGKDVFQKKKLGCQLLGKYKQIIAVLAQAF((Disulfide bridge:Cys12-Cys134,Cys18-Cys131,Cys60-Cys163) |
| Formula | C884H815N245O251S7 |
| Molar Mass | 19110.84 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
Emfilermin
CAS: 159075-60-2 F: C884H815N245O251S7 W: 19110.84
Emfilermin is a recombinant human leukaemia inhibitory factor (LIF) that can be used in chemotherapy-induced peripheral
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.